513
Views
4
CrossRef citations to date
0
Altmetric
RESEARCH ARTICLE

Treatment for intermediate and high-risk prostate cancer: Controversial issues and the role of hyperthermia

, &
Pages 765-774 | Received 23 Mar 2010, Accepted 16 Jul 2010, Published online: 02 Nov 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nicholas G Zaorsky, Robert B Den, Laura A Doyle, Adam P Dicker & Mark D Hurwitz. (2013) Combining theoretical potential and advanced technology in high-dose rate brachytherapy boost therapy for prostate cancer. Expert Review of Medical Devices 10:6, pages 751-763.
Read now

Articles from other publishers (3)

Ye. L. Choinzonov, O. V. Gribova, Zh. A. Startseva, A. I. Ryabova, V. A. Novikov, L. I. Musabayeva & I. S. Polezhayeva. (2014) CURRENT APPROACHES TO CHEMORADIOTHERAPY FOR MALIGNANT GLIOMAS. Bulletin of Siberian Medicine 13:3, pages 119-125.
Crossref
Fukashi YamamichiKatsumi ShigemuraShinichi MorishitaKunito YamanakaKazushi TanakaHideaki MiyakeMasato Fujisawa. (2013) Significance of Neoadjuvant Hormonal Therapy in Radical Retropubic Prostatectomy: A Retrospective Single-Surgeon Study. Yonsei Medical Journal 54:2, pages 410.
Crossref
Hidenobu Fukumura, Motohiko Sato, Kyouhei Kezuka, Itaru Sato, Xianfeng Feng, Satoshi Okumura, Takayuki Fujita, Utako Yokoyama, Haruki Eguchi, Yoshihiro Ishikawa & Tomoyuki Saito. (2012) Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells. The Journal of Physiological Sciences 62:3, pages 251-257.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.